Shares of Boston Scientific rose sharply Wednesday after the firm posted better-than-expected quarterly results.

Medical device company Boston Scientific (NYSE:BSX) reported in Q1 CY2025, with sales up 20.9% year on year to $4.66 billion.

Q1 2025 Earnings Call Transcript April 23, 2025 Boston Scientific Corporation beats earnings expectations. Reported EPS is $0 ...

Boston Scientific stock is up as company officials predict that the ongoing trade war won't hinder double-digit sales growth ...

Analysts expect Boston Scientific to report an earnings per share (EPS) of $0.67. Boston Scientific bulls will hope to hear ...

Boston Scientific (BSX) came out with quarterly ... The company has topped consensus revenue estimates four times over the last four quarters. The sustainability of the stock's immediate price ...

Boston Scientific said that while tariffs pose “unfortunate” headwinds—which are poised to add about $200 million to the cost ...

These margin improvements reflect the company’s operational efficiency and favorable product mix. Boston Scientific’s revenue breakdown reveals the strong contribution from both major segments. The ...

Q1 revenue hit $4.66 billion vs ... Claim your 7-day free trial now. Boston Scientific Corporation BSX on Wednesday reported first-quarter 2025 revenues of $4.66 billion, beating the consensus ...

Reports Q1 revenue $4.66B, consensus $4.57B. “We delivered an exceptional quarter to start the year, reflecting the effectiveness of our highly ...

Medical device company Boston Scientific (NYSE:BSX) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 20.9% year on year to $4.66 billion. Guidance for next ...